Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGeraldes, Ruth
dc.contributor.authorJuryńczyk, Maciej
dc.contributor.authorPassos, Giordani
dc.contributor.authorPichler, Alexander
dc.contributor.authorHagens, Marloes
dc.contributor.authorAuger Acosta, Cristina
dc.contributor.authorRovira Cañellas, Alex
dc.contributor.authorSastre Garriga, Jaume
dc.contributor.authorChung, Karen
dc.date.accessioned2022-01-14T09:28:31Z
dc.date.available2022-01-14T09:28:31Z
dc.date.copyright2020
dc.date.issued2021-05
dc.identifier.citationGeraldes R, Juryńczyk M, Rodrigues dos Passos G, Pichler A, Chung K, Hagens M, et al. The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease. Mult Scler J. 2021 May;27(6):968–72.
dc.identifier.issn1352-4585
dc.identifier.urihttps://hdl.handle.net/11351/6799
dc.descriptionMultiple sclerosis; Differential diagnosis; Imaging
dc.description.abstractBackground: Differentiating multiple sclerosis (MS) from vascular risk factor (VRF)-small vessel disease (SVD) can be challenging. Objective and Methods: In order to determine whether or not pontine lesion location is a useful discriminator of MS and VRF-SVD, we classified pontine lesions on brain magnetic resonance imaging (MRI) as central or peripheral in 93 MS cases without VRF, 108 MS patients with VRF and 43 non-MS cases with VRF. Results: MS without VRF were more likely to have peripheral pons lesions (31.2%, 29/93) than non-MS with VRF (0%, 0/43) (Exp(B) = 29.8; 95% confidence interval (CI) = (1.98, 448.3); p = 0.014) but there were no significant differences regarding central pons lesions between MS without VRF (5.4%, 5/93) and non-MS with VRF patients (16.3%, 7/43) (Exp(B) = 0.89; 95% CI = (0.2, 3.94); p = 0.87). The presence of peripheral pons lesions discriminated between MS and VRF-SVD with 100% (95% CI = (91.8, 100)) specificity. The proportion of peripheral pons lesions in MS with VRF (30.5%, 33/108) was similar to that seen in MS without VRF (31.2%, 29/93, p = 0.99). Central lesions occurred in similar frequency in MS with VRF (8.3%, 9/108) and non-MS with VRF (16.3%, 7/43, p = 0.15). Conclusion: Peripheral pons lesion location is a good discriminator of MS from vascular lesions.
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesMultiple Sclerosis Journal;27(6)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectEsclerosi múltiple
dc.subjectCervell - Vasos sanguinis - Malalties
dc.subjectImatgeria per ressonància magnètica
dc.subject.meshMagnetic Resonance Imaging
dc.subject.meshMultiple Sclerosis
dc.subject.meshCerebral Small Vessel Diseases
dc.titleThe role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1177/1352458520943777
dc.subject.decsimagen por resonancia magnética
dc.subject.decsesclerosis múltiple
dc.subject.decsenfermedades de los pequeños vasos cerebrales
dc.relation.publishversionhttps://doi.org/10.1177/1352458520943777
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Geraldes R, Juryńczyk M, Rodrigues dos Passos G] Nuffield Department of Clinical Neurosciences, Oxford, UK. [Pichler A] Department of Neurology, Medical University of Graz, Graz, Austria/Division of Neuroradiology, Vascular & Interventional Radiology, Medical University of Graz, Graz, Austria. [Chung K] NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Institute of Neurology, London, UK. [Hagens M] MS Center Amsterdam, Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. [Auger C, Rovira A] Secció de Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sastre-Garriga J] Servei de Neurologia/ Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid32757905
dc.identifier.wos000556869200001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record